Literature DB >> 14994114

Randomized, prospective trial comparing 0.2 percent isosorbide dinitrate ointment with sphincterotomy in treatment of chronic anal fissure: a two-year follow-up.

Carlos Parellada1.   

Abstract

PURPOSE: The aim of this trial was to compare lateral internal sphincterotomy with local 0.2 percent isosorbide dinitrate in the treatment of chronic anal fissure to minimize surgical complications such as minor fecal incontinence.
METHODS: Fifty-four patients with chronic anal fissure were randomized in a prospective trial to either sphincterotomy or local 0.2 percent isosorbide dinitrate. All patients had anal function tests before and 5 weeks after treatment.
RESULTS: In the ointment group, 18 patients (67 percent) healed at 5 weeks and 24 (89 percent) healed at 10 weeks of treatment. Maximum resting anal pressure was reduced 30 percent. Eight patients (30 percent) had minor side effects. In the surgical group, 26 patients (96 percent) healed at 5 weeks and 100 percent healed at 10 weeks after treatment, with 33 percent reduction in maximum resting anal pressure. Forty-four percent of patients had minor fecal incontinence, which remained in 15 percent after 24 months follow-up. No statistical difference in maximum resting anal pressure was found between groups ( P = 0.16), but the percentage of healing at 5 weeks was greater in the surgical group ( P < 0.001).
CONCLUSIONS: Isosorbide dinitrate ointment must be considered as the first choice of treatment in patients with chronic anal fissure. Surgery should be indicated if chemical sphincterotomy fails.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14994114     DOI: 10.1007/s10350-003-0090-x

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  13 in total

Review 1.  Current concepts in anal fissures.

Authors:  Abraham A Ayantunde; Samuel A Debrah
Journal:  World J Surg       Date:  2006-12       Impact factor: 3.352

Review 2.  A review of chronic anal fissure management.

Authors:  E E Collins; J N Lund
Journal:  Tech Coloproctol       Date:  2007-08-03       Impact factor: 3.781

Review 3.  Anal fissure (chronic).

Authors:  Richard L Nelson
Journal:  BMJ Clin Evid       Date:  2014-11-12

4.  Efficacy of lanolin and bovine type I collagen in the treatment of childhood anal fissures: a prospective, randomized, controlled clinical trial.

Authors:  Behçet Ilker Büyükyavuz; Cagri Savaş; Levent Duman
Journal:  Surg Today       Date:  2010-07-30       Impact factor: 2.549

Review 5.  Non surgical therapy for anal fissure.

Authors:  Richard L Nelson; Kathryn Thomas; Jenna Morgan; Abigail Jones
Journal:  Cochrane Database Syst Rev       Date:  2012-02-15

Review 6.  A systematic review and meta-analysis of the treatment of anal fissure.

Authors:  R L Nelson; D Manuel; C Gumienny; B Spencer; K Patel; K Schmitt; D Castillo; A Bravo; A Yeboah-Sampong
Journal:  Tech Coloproctol       Date:  2017-08-09       Impact factor: 3.781

7.  Effect of chronic anal fissure components on isosorbide dinitrate treatment.

Authors:  K Arslan; B Erenoğlu; O Doğru; S Kökçam; E Turan; A Atay
Journal:  World J Surg       Date:  2012-09       Impact factor: 3.352

8.  Optimal treatment duration of glyceryl trinitrate for chronic anal fissure: results of a prospective randomized multicenter trial.

Authors:  G Gagliardi; A Pascariello; D F Altomare; F Arcanà; D Cafaro; F La Torre; P De Nardi; L Basso; I De Stefano; V J Greco; L Vasapollo; A Amato; A Pulvirenti D'Urso; D Aiello; A Bove
Journal:  Tech Coloproctol       Date:  2010-07-15       Impact factor: 3.781

9.  Lateral internal sphincterotomy versus 0.25 % isosorbide dinitrate ointment for chronic anal fissures: a prospective randomized controlled trial.

Authors:  Kemal Arslan; Bülent Erenoğlu; Osman Doğru; Ersin Turan; Mehmet Ali Eryilmaz; Arif Atay; Said Kökçam
Journal:  Surg Today       Date:  2012-09-09       Impact factor: 2.549

10.  Conservative versus surgical treatment for chronic anal idiopathic fissure: a prospective randomized trial.

Authors:  Michele de Rosa; Giovanni Cestaro; Chiara Vitiello; Salvatore Massa; Maurizio Gentile
Journal:  Updates Surg       Date:  2013-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.